Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Dynamic Pharmaceuticals Powershares (PJP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fund basics

See More

Price Performance

See More
Period Period Low Period High Performance
1-Month
58.50 +0.24%
on 05/22/17
61.13 -4.07%
on 05/02/17
-2.02 (-3.33%)
since 04/26/17
3-Month
57.88 +1.31%
on 04/05/17
61.76 -5.05%
on 02/27/17
-2.34 (-3.84%)
since 02/24/17
52-Week
53.55 +9.51%
on 11/04/16
69.24 -15.31%
on 08/04/16
-5.07 (-7.96%)
since 05/26/16

Most Recent Stories

More News
Gilead Sciences Posts Mixed Q1 Results: ETFs in Focus

Gilead beat Zacks EPS estimates, but missed on revenue, in the first quarter of 2017.

PJP : 58.64 (-0.81%)
IBB : 288.22 (-0.79%)
BBH : 117.48 (-0.25%)
GILD : 64.50 (-0.09%)
Gilead Sciences Posts Mixed Q1 Results: ETFs in Focus

Gilead beat Zacks EPS estimates, but missed on revenue, in the first quarter of 2017.

PJP : 58.64 (-0.81%)
IBB : 288.22 (-0.79%)
BBH : 117.48 (-0.25%)
GILD : 64.50 (-0.09%)
Implied PJP Analyst Target Price: $72

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...

PJP : 58.64 (-0.81%)
Trumpcare Collapse Fuels Rally in Healthcare Stocks & ETFs

With the failure of Trumpcare, the healthcare sector looks more stable.

UHS : 116.07 (-1.06%)
BBC : 21.63 (-2.70%)
AC : 34.20 (+1.03%)
XLV : 75.89 (-0.18%)
IHE : 150.39 (-0.39%)
MOH : 66.87 (-0.31%)
LPNT : 62.45 (-0.64%)
THC : 17.45 (-0.80%)
BBP : 35.97 (-1.32%)
XPH : 41.75 (-0.07%)
PBE : 42.45 (-0.59%)
SBIO : 24.86 (-1.54%)
PJP : 58.64 (-0.81%)
CNC : 74.57 (-0.90%)
SPY : 241.71 (-0.02%)
XBI : 68.72 (-1.49%)
Trumpcare Collapse Fuels Rally in Healthcare Stocks & ETFs

With the failure of Trumpcare, the healthcare sector looks more stable.

UHS : 116.07 (-1.06%)
BBC : 21.63 (-2.70%)
AC : 34.20 (+1.03%)
XLV : 75.89 (-0.18%)
IHE : 150.39 (-0.39%)
MOH : 66.87 (-0.31%)
LPNT : 62.45 (-0.64%)
THC : 17.45 (-0.80%)
BBP : 35.97 (-1.32%)
XPH : 41.75 (-0.07%)
PBE : 42.45 (-0.59%)
SBIO : 24.86 (-1.54%)
PJP : 58.64 (-0.81%)
CNC : 74.57 (-0.90%)
SPY : 241.71 (-0.02%)
XBI : 68.72 (-1.49%)
Trump, Biogen and Amgen Hammer Healthcare ETFs

After making a strong comeback in February, the U.S. healthcare sector again witnessed some pain in the last couple of sessions.

CELG : 116.78 (+0.03%)
XLV : 75.89 (-0.18%)
VHT : 140.65 (-0.21%)
MDCO : 39.14 (-0.63%)
IBB : 288.22 (-0.79%)
PFE : 32.14 (-0.06%)
ESPR : 32.83 (-1.35%)
BBP : 35.97 (-1.32%)
XPH : 41.75 (-0.07%)
ABT : 44.71 (+1.73%)
TMO : 173.42 (+0.30%)
PJP : 58.64 (-0.81%)
IYH : 158.70 (-0.22%)
AMG : 153.92 (-0.05%)
BIIB : 250.80 (-0.86%)
Trump, Biogen and Amgen Hammer Healthcare ETFs

After making a strong comeback in February, the U.S. healthcare sector again witnessed some pain in the last couple of sessions.

CELG : 116.78 (+0.03%)
XLV : 75.89 (-0.18%)
VHT : 140.65 (-0.21%)
MDCO : 39.14 (-0.63%)
IBB : 288.22 (-0.79%)
PFE : 32.14 (-0.06%)
ESPR : 32.83 (-1.35%)
BBP : 35.97 (-1.32%)
XPH : 41.75 (-0.07%)
ABT : 44.71 (+1.73%)
TMO : 173.42 (+0.30%)
PJP : 58.64 (-0.81%)
IYH : 158.70 (-0.22%)
AMG : 153.92 (-0.05%)
BIIB : 250.80 (-0.86%)
Should You Buy Pharma ETFs Now?

After a challenging 2016, are Pharma ETFs poised to rebound this year?

XPH : 41.75 (-0.07%)
PJP : 58.64 (-0.81%)
IHE : 150.39 (-0.39%)
PPH : 57.08 (-0.63%)
Should You Buy Pharma ETFs Now?

After a challenging 2016, are Pharma ETFs poised to rebound this year?

XPH : 41.75 (-0.07%)
PJP : 58.64 (-0.81%)
IHE : 150.39 (-0.39%)
PPH : 57.08 (-0.63%)
Trump Tweet on Drug Pricing Hits Biotech and Pharma ETFs

President Donald Trump March 7 tweet on increasing competition and lowering drug prices sent fresh shockwaves across the industry.

BBC : 21.63 (-2.70%)
JNJ : 126.92 (-0.48%)
SUPN : 35.75 (+4.69%)
AGN : 223.12 (-0.55%)
IBB : 288.22 (-0.79%)
IONS : 46.38 (+0.06%)
NVS : 80.63 (-0.89%)
GNRX : 22.20 (-0.09%)
PFE : 32.14 (-0.06%)
BMY : 53.97 (-0.77%)
XPH : 41.75 (-0.07%)
ENDP : 13.12 (+1.78%)
PJP : 58.64 (-0.81%)
LLY : 78.05 (-0.37%)
VRX : 12.83 (+0.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More

Fund Summary

The PowerShares Dynamic Pharmaceuticals Portfolio ("the Fund") seeks investment results that correspond generally to the price and yield (before the Fund's fees and expenses) of an equity index called the Dynamic Pharmaceuticals Intellidex Index (the "Underlying Intellidex"). The Underlying Intellidex...

See More

Support & Resistance

2nd Resistance Point 59.15
1st Resistance Point 58.90
Last Price 58.64
1st Support Level 58.48
2nd Support Level 58.31

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.